APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Injectable

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Contraceptive Injectable Market Outlook and Growth Opportunities 2026

Report ID 173980750421 December 2025190 pages

Choose your research edition.

Industry ResearchContraceptive Injectable Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Injectable Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Contraceptive Injectable Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Injectable Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Injectable Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Injectable market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Contraceptive Injectable market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Contraceptive Injectable market include Janssen Pharmaceuticals, Inc., Pfizer Inc., China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Bayer AG, Veru, Inc., Organon Group Of Companies, Church & Dwight, Agile Therapeutics and Afaxys, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Injectable market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Injectable and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Injectable sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Injectable market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Injectable Segment by Company

Janssen Pharmaceuticals, Inc.

Pfizer Inc.

China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

Bayer AG

Veru, Inc.

Organon Group Of Companies

Church & Dwight

Agile Therapeutics

Afaxys, Inc.

Contraceptive Injectable Segment by Type

Long-Acting Contraception

Short-Acting Contraception

Contraceptive Injectable Segment by Application

Male

Female

Contraceptive Injectable Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contraceptive Injectable status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contraceptive Injectable market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contraceptive Injectable significant trends, drivers, influence factors in global and regions.

6. To analyze Contraceptive Injectable competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Injectable.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Injectable market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contraceptive Injectable industry.

Chapter 3: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contraceptive Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contraceptive Injectable in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Injectable Industry Trends Table 2. Contraceptive Injectable Industry Drivers Table 3. Contraceptive Injectable Industry Opportunities and Challenges Table 4. Contraceptive Injectable Industry Restraints Table 5. Global Contraceptive Injectable Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contraceptive Injectable Revenue Share by Company (2021-2026) Table 7. Global Contraceptive Injectable Sales Volume by Company (k units) & (2021-2026) Table 8. Global Contraceptive Injectable Sales Volume Share by Company (2021-2026) Table 9. Global Contraceptive Injectable Average Price (US$/unit) of Company (2021-2026) Table 10. Global Contraceptive Injectable Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contraceptive Injectable Key Company Manufacturing Base & Headquarters Table 12. Global Contraceptive Injectable Company, Product Type & Application Table 13. Global Contraceptive Injectable Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Long-Acting Contraception Table 18. Significant Companies of Short-Acting Contraception Table 19. Global Contraceptive Injectable Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Contraceptive Injectable Sales Volume by Type (2021-2026) & (k units) Table 21. Global Contraceptive Injectable Sales Volume by Type (2027-2032) & (k units) Table 22. Global Contraceptive Injectable Sales Volume Share by Type (2021-2026) Table 23. Global Contraceptive Injectable Sales Volume Share by Type (2027-2032) Table 24. Global Contraceptive Injectable Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Contraceptive Injectable Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Contraceptive Injectable Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Contraceptive Injectable Sales Value Share by Type (2021-2026) Table 28. Global Contraceptive Injectable Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Male Table 30. Significant Companies of Female Table 31. Global Contraceptive Injectable Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Contraceptive Injectable Sales Volume by Application (2021-2026) & (k units) Table 33. Global Contraceptive Injectable Sales Volume by Application (2027-2032) & (k units) Table 34. Global Contraceptive Injectable Sales Volume Share by Application (2021-2026) Table 35. Global Contraceptive Injectable Sales Volume Share by Application (2027-2032) Table 36. Global Contraceptive Injectable Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Contraceptive Injectable Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Contraceptive Injectable Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Contraceptive Injectable Sales Value Share by Application (2021-2026) Table 40. Global Contraceptive Injectable Sales Value Share by Application (2027-2032) Table 41. Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Contraceptive Injectable Sales by Region (2021-2026) & (k units) Table 43. Global Contraceptive Injectable Sales Market Share by Region (2021-2026) Table 44. Global Contraceptive Injectable Sales by Region (2027-2032) & (k units) Table 45. Global Contraceptive Injectable Sales Market Share by Region (2027-2032) Table 46. Global Contraceptive Injectable Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Contraceptive Injectable Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Contraceptive Injectable Sales Value Share by Region (2021-2026) Table 49. Global Contraceptive Injectable Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Contraceptive Injectable Sales Value Share by Region (2027-2032) Table 51. Global Contraceptive Injectable Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Contraceptive Injectable Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Contraceptive Injectable Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Contraceptive Injectable Sales by Country (2021-2026) & (k units) Table 56. Global Contraceptive Injectable Sales Market Share by Country (2021-2026) Table 57. Global Contraceptive Injectable Sales by Country (2027-2032) & (k units) Table 58. Global Contraceptive Injectable Sales Market Share by Country (2027-2032) Table 59. Global Contraceptive Injectable Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Contraceptive Injectable Sales Value Market Share by Country (2021-2026) Table 61. Global Contraceptive Injectable Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Contraceptive Injectable Sales Value Market Share by Country (2027-2032) Table 63. Janssen Pharmaceuticals, Inc. Company Information Table 64. Janssen Pharmaceuticals, Inc. Business Overview Table 65. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio Table 67. Janssen Pharmaceuticals, Inc. Recent Development Table 68. Pfizer Inc. Company Information Table 69. Pfizer Inc. Business Overview Table 70. Pfizer Inc. Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Pfizer Inc. Contraceptive Injectable Product Portfolio Table 72. Pfizer Inc. Recent Development Table 73. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information Table 74. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview Table 75. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio Table 77. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Development Table 78. Bayer AG Company Information Table 79. Bayer AG Business Overview Table 80. Bayer AG Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Bayer AG Contraceptive Injectable Product Portfolio Table 82. Bayer AG Recent Development Table 83. Veru, Inc. Company Information Table 84. Veru, Inc. Business Overview Table 85. Veru, Inc. Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Veru, Inc. Contraceptive Injectable Product Portfolio Table 87. Veru, Inc. Recent Development Table 88. Organon Group Of Companies Company Information Table 89. Organon Group Of Companies Business Overview Table 90. Organon Group Of Companies Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Organon Group Of Companies Contraceptive Injectable Product Portfolio Table 92. Organon Group Of Companies Recent Development Table 93. Church & Dwight Company Information Table 94. Church & Dwight Business Overview Table 95. Church & Dwight Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Church & Dwight Contraceptive Injectable Product Portfolio Table 97. Church & Dwight Recent Development Table 98. Agile Therapeutics Company Information Table 99. Agile Therapeutics Business Overview Table 100. Agile Therapeutics Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Agile Therapeutics Contraceptive Injectable Product Portfolio Table 102. Agile Therapeutics Recent Development Table 103. Afaxys, Inc. Company Information Table 104. Afaxys, Inc. Business Overview Table 105. Afaxys, Inc. Contraceptive Injectable Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Afaxys, Inc. Contraceptive Injectable Product Portfolio Table 107. Afaxys, Inc. Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Contraceptive Injectable Distributors List Table 111. Contraceptive Injectable Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Contraceptive Injectable Product Image Figure 2. Global Contraceptive Injectable Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Injectable Sales (2021-2032) & (k units) Figure 5. Global Contraceptive Injectable Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Contraceptive Injectable Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Long-Acting Contraception Image Figure 10. Short-Acting Contraception Image Figure 11. Global Contraceptive Injectable Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Contraceptive Injectable Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Contraceptive Injectable Sales Volume Share by Type (2021-2032) Figure 14. Global Contraceptive Injectable Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Contraceptive Injectable Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Contraceptive Injectable Sales Value Share by Type (2021-2032) Figure 17. Male Image Figure 18. Female Image Figure 19. Global Contraceptive Injectable Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Contraceptive Injectable Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Contraceptive Injectable Sales Volume Share by Application (2021-2032) Figure 22. Global Contraceptive Injectable Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Contraceptive Injectable Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Contraceptive Injectable Sales Value Share by Application (2021-2032) Figure 25. Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Contraceptive Injectable Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Contraceptive Injectable Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Contraceptive Injectable Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 30. North America Contraceptive Injectable Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Contraceptive Injectable Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Contraceptive Injectable Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 36. South America Contraceptive Injectable Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Contraceptive Injectable Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Contraceptive Injectable Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Contraceptive Injectable Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Contraceptive Injectable Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Contraceptive Injectable Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Long-Acting Contraception
  • Short-Acting Contraception
Applications
  • Male
  • Female
Companies covered
  • Janssen Pharmaceuticals, Inc.
  • Pfizer Inc.
  • China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  • Bayer AG
  • Veru, Inc.
  • Organon Group Of Companies
  • Church & Dwight
  • Agile Therapeutics
  • Afaxys, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptive Injectable Sales Value (2021-2032)
  4. 1.2.2 Global Contraceptive Injectable Sales Volume (2021-2032)
  5. 1.2.3 Global Contraceptive Injectable Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contraceptive Injectable Market Dynamics
  1. 2.1 Contraceptive Injectable Industry Trends
  2. 2.2 Contraceptive Injectable Industry Drivers
  3. 2.3 Contraceptive Injectable Industry Opportunities and Challenges
  4. 2.4 Contraceptive Injectable Industry Restraints
3 Contraceptive Injectable Market by Company
  1. 3.1 Global Contraceptive Injectable Company Revenue Ranking in 2025
  2. 3.2 Global Contraceptive Injectable Revenue by Company (2021-2026)
  3. 3.3 Global Contraceptive Injectable Sales Volume by Company (2021-2026)
  4. 3.4 Global Contraceptive Injectable Average Price by Company (2021-2026)
  5. 3.5 Global Contraceptive Injectable Company Ranking (2024-2026)
  6. 3.6 Global Contraceptive Injectable Company Manufacturing Base and Headquarters
  7. 3.7 Global Contraceptive Injectable Company Product Type and Application
  8. 3.8 Global Contraceptive Injectable Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contraceptive Injectable Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contraceptive Injectable Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contraceptive Injectable Market by Type
  1. 4.1 Contraceptive Injectable Type Introduction
  2. 4.1.1 Long-Acting Contraception
  3. 4.1.2 Short-Acting Contraception
  4. 4.2 Global Contraceptive Injectable Sales Volume by Type
  5. 4.2.1 Global Contraceptive Injectable Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Contraceptive Injectable Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Contraceptive Injectable Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Contraceptive Injectable Sales Value by Type
  9. 4.3.1 Global Contraceptive Injectable Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Contraceptive Injectable Sales Value by Type (2021-2032)
  11. 4.3.3 Global Contraceptive Injectable Sales Value Share by Type (2021-2032)
5 Contraceptive Injectable Market by Application
  1. 5.1 Contraceptive Injectable Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Contraceptive Injectable Sales Volume by Application
  5. 5.2.1 Global Contraceptive Injectable Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contraceptive Injectable Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Contraceptive Injectable Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Contraceptive Injectable Sales Value by Application
  9. 5.3.1 Global Contraceptive Injectable Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contraceptive Injectable Sales Value by Application (2021-2032)
  11. 5.3.3 Global Contraceptive Injectable Sales Value Share by Application (2021-2032)
6 Contraceptive Injectable Regional Sales and Value Analysis
  1. 6.1 Global Contraceptive Injectable Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Injectable Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Injectable Sales by Region: 2021-2026
  4. 6.2.2 Global Contraceptive Injectable Sales by Region (2027-2032)
  5. 6.3 Global Contraceptive Injectable Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contraceptive Injectable Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contraceptive Injectable Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contraceptive Injectable Sales Value by Region (2027-2032)
  9. 6.5 Global Contraceptive Injectable Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contraceptive Injectable Sales Value (2021-2032)
  12. 6.6.2 North America Contraceptive Injectable Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contraceptive Injectable Sales Value (2021-2032)
  15. 6.7.2 Europe Contraceptive Injectable Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contraceptive Injectable Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contraceptive Injectable Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contraceptive Injectable Sales Value (2021-2032)
  21. 6.9.2 South America Contraceptive Injectable Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contraceptive Injectable Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contraceptive Injectable Sales Value Share by Country, 2025 VS 2032
7 Contraceptive Injectable Country-level Sales and Value Analysis
  1. 7.1 Global Contraceptive Injectable Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contraceptive Injectable Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contraceptive Injectable Sales by Country (2021-2032)
  4. 7.3.1 Global Contraceptive Injectable Sales by Country (2021-2026)
  5. 7.3.2 Global Contraceptive Injectable Sales by Country (2027-2032)
  6. 7.4 Global Contraceptive Injectable Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contraceptive Injectable Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contraceptive Injectable Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contraceptive Injectable Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contraceptive Injectable Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contraceptive Injectable Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceuticals, Inc.
  2. 8.1.1 Janssen Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Janssen Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
  6. 8.1.5 Janssen Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Pfizer Inc.
  8. 8.2.1 Pfizer Inc. Company Information
  9. 8.2.2 Pfizer Inc. Business Overview
  10. 8.2.3 Pfizer Inc. Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
  12. 8.2.5 Pfizer Inc. Recent Developments
  13. 8.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
  14. 8.3.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
  15. 8.3.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview
  16. 8.3.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
  18. 8.3.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments
  19. 8.4 Bayer AG
  20. 8.4.1 Bayer AG Company Information
  21. 8.4.2 Bayer AG Business Overview
  22. 8.4.3 Bayer AG Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer AG Contraceptive Injectable Product Portfolio
  24. 8.4.5 Bayer AG Recent Developments
  25. 8.5 Veru, Inc.
  26. 8.5.1 Veru, Inc. Company Information
  27. 8.5.2 Veru, Inc. Business Overview
  28. 8.5.3 Veru, Inc. Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Veru, Inc. Contraceptive Injectable Product Portfolio
  30. 8.5.5 Veru, Inc. Recent Developments
  31. 8.6 Organon Group Of Companies
  32. 8.6.1 Organon Group Of Companies Company Information
  33. 8.6.2 Organon Group Of Companies Business Overview
  34. 8.6.3 Organon Group Of Companies Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
  36. 8.6.5 Organon Group Of Companies Recent Developments
  37. 8.7 Church & Dwight
  38. 8.7.1 Church & Dwight Company Information
  39. 8.7.2 Church & Dwight Business Overview
  40. 8.7.3 Church & Dwight Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Church & Dwight Contraceptive Injectable Product Portfolio
  42. 8.7.5 Church & Dwight Recent Developments
  43. 8.8 Agile Therapeutics
  44. 8.8.1 Agile Therapeutics Company Information
  45. 8.8.2 Agile Therapeutics Business Overview
  46. 8.8.3 Agile Therapeutics Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
  48. 8.8.5 Agile Therapeutics Recent Developments
  49. 8.9 Afaxys, Inc.
  50. 8.9.1 Afaxys, Inc. Company Information
  51. 8.9.2 Afaxys, Inc. Business Overview
  52. 8.9.3 Afaxys, Inc. Contraceptive Injectable Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
  54. 8.9.5 Afaxys, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Injectable Value Chain Analysis
  2. 9.1.1 Contraceptive Injectable Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Injectable Sales Mode & Process
  6. 9.2 Contraceptive Injectable Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Injectable Distributors
  9. 9.2.3 Contraceptive Injectable Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst